Safety by Design
Light-based therapy for the eye is only useful if it is safe, and safety on Espansione's platform is built into the technology rather than bolted on. The two modalities have different profiles, and being precise about each is part of responsible practice.
LLLT: non-invasive and non-thermal
LM™ LLLT (PBM) delivers non-ionising, monochromatic light below the threshold at which it would heat or damage tissue. There is no thermal ablation and no incision; the treatment is painless, requires no anaesthesia and has no downtime. As Professor James Wolffsohn has noted in describing his own early adoption, low-level light therapy has a favourable safety profile with no absolute contraindications identified, which is valuable when many patients are already managing multiple medications.
IPL: self-modulating and gel-free
OPE™ IPL is engineered to be among the safest IPL systems available. Its intensity self-modulates toward a skin-safe optimum, which is what allows it to be used without gel. Because IPL delivers light to the skin, it still warrants screening for photosensitising medications and a history of photosensitivity reactions before treatment.
Adverse events are rare and usually preventable
Across the platform, adverse events are uncommon and are predominantly attributable to incorrect mask positioning or to undisclosed photosensitisers, rather than to the technology itself. Correct technique, a complete history and adherence to the device Instructions for Use are the practical safeguards.
Clinical governance completes the picture
The TFOS DEWS III report is candid that the contraindication and precaution literature for both LLLT and IPL is not exhaustively defined. The appropriate framework, therefore, is clinical judgement supported by informed consent and review of the device IFU. This is also why professional oversight is central to Espansione's model and why a regulated medical device differs so fundamentally from a consumer light gadget: a trained clinician diagnoses the condition, selects the protocol and monitors the response.
Not all solutions and indications are cleared in all countries and for all cohorts. Every piece of information ought to be considered as fact-based evidence deriving from publicly available literature, for the sole purpose of scientific exchange.